Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW856553 PET/CT study in atherosclerosis
2007-005338-35Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of losmapimod in atherosclerosis (3 arms), sponsored by GSK. Primary endpoint: Change in mean FDG uptake in aortic and carotid arteries. Started Feb 2008; status: completed.
02
Drugs
losmapimod
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on 2007-005338-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005338-35.